Total Funding
87
58
Total FundingDebt Financing raised
Growth Score
-3 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
47508
Immutrix Therapeutics is a medical tech company that has developed a medical device for cleansing the blood.
Dan Smith: CEO/CFO- Dan Smith: COO
About the Company
Immutrix Therapeutics s is a medical tech company that develops and markets blood cleansing treatment device. The company's product removes inflammatory mediators and toxins from blood using proprietary adsorbents and smart hollow fiber membranes.
Immutrix products target and bind molecules (modifiers) of interest in a
"dialysis-like" procedure to treat a broad range of medical conditions. The modifiers to be removed are those molecules which cause an undesired immune or pathological response, often referred to as mediators.
The company was incorporated in 2009 and is based in Rapid City, South Dakota.
Women Founded
Women Led
